CELG Stock Current Trading Information 05/03/2014 23:36:10

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
Friday Celgene Corp (CELG) $CELG opened at 149.54 hitting the high price of 149.57 and a day low of 146.23 with a total volume of 2,642,600. CELG had a previous close of 148.80 and has been seeing an average volume of 3,947,735.

Overall Average: 16% Sell

Recent stock forum discussions about CELG http://investorshangout.com/search?q=CELG&...mp;yt0=Go!

Final Glance: Biotechnology companies
AP - Fri May 02, 5:02PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were down at the close of trading: (full story)

Midday Glance: Biotechnology companies
AP - Fri May 02, 12:30PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are down at 1 p.m.: (full story)

Early Glance: Biotechnology companies
AP - Fri May 02, 9:33AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are down at 10 a.m.: (full story)

Biotech Sector Performance in April: Gilead Sciences Rising
at The Street - Fri May 02, 8:49AM CDT
The biotech sector was down again, but there's some hopeful signs of a recovery. (full story)

New Drug Applications, Quarterly Results, and University Partnerships - Analyst Notes on Celgene, HCA, Thermo Fisher Scientific, Cubist and Agilent
PR Newswire - Fri May 02, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Celgene Corporation (NASDAQ: CELG), HCA Holdings Inc. (NYSE: HCA), Thermo Fisher Scientific Inc. (NYSE: TMO), Cubist Pharmaceuticals Inc. (NASDAQ: CBST) and Agilent Technologies Inc. (NYSE: A). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1941-100free. (full story)

Health Care Stocks Still Healthy Despite Higher Hedging Costs
at The Street - Fri May 02, 5:30AM CDT
Health care is still outperforming the overall indices -- mergers and stellar sales figures and all. Can it be sustained? (full story)

Up 50%: Merrimack Pharmaceuticals' Groundbreaking News
Michael Douglass and David Williamson, The Motley Fool - Motley Fool - Thu May 01, 5:30PM CDT
Shares in  Merrimack Pharmaceuticals  (NASDAQ: MACK) gained over 50% today on great news regarding a phase 3 trial for its MM-398 drug for pancreatic cancer. In combination with 5-flouroacil and leucovorin, MM-398 generated a 1.9 month lift in... (full story)

Critical Alerts For Coca Cola, Baidu.com, Urban Outfitters, Celgene, and Trina Solar Released By InvestorsObserver
PR Newswire - Thu May 01, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for KO, BIDU, URBN, CELG, and TSL. (full story)

Biotech Stock Roundup: Gilead's Sovaldi Shines, Biogen & Alexion Up Outlook - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Apr 30, 9:55AM CDT
Gilead's (GILD) Sovaldi remained in the limelight with sales blowing past expectations. (full story)

Earnings Roundup: Celgene's Rock-Solid Quarter Offers Opportunity
Todd Campbell, The Motley Fool - Motley Fool - Tue Apr 29, 5:30PM CDT
Celgene is one of the most prolific deal makers in the biotech industry, inking dozens of collaborations with emerging biotechs working on the next big thing in medicine. Celgene's collaborations aim to expand upon an already-impressive... (full story)

After Yesterday's Rally of 2.75% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Apr 29, 3:45PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $142.10 to a high of $148.00. Yesterday, the shares gained 2.8%, which took the trading range above the 3-day high of $144.95 on volume of 3.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious. (full story)

Celgene Rises 2.75% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Apr 29, 3:45PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $142.10 to a high of $148.00. Yesterday, the shares gained 2.8%, which took the trading range above the 3-day high of $144.95 on volume of 3.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious. (full story)

Celgene Deal Chief Calls Big Pharma Gutless For Lack of Biotech M&A
at The Street - Tue Apr 29, 3:26PM CDT
Some sharp opinions expressed by healthcare deal-makers at the Allicense 2014 conference. (full story)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

M&A Source's 2026 Conference Tackles Deal-Making Drama

Updated Category News Views 84

High Stakes and Deep Insights Await in Houston Cracking the nut of lower-middle market transactions ain’t a walk in the park. M&A Source®'s Fall 2026 Conference is gearing up to address the very dramas that lurk behind the scenes. Kicking off November 2-4 at the opulent JW Marriott in Houston, Texas, the event is looking to assemble a heavyweight lineup of...

Continue Reading
Co-Diagnostics Nearing India TB Test Launch By 2026

Updated Category News Views 98

Co-Diagnostics Gears Up for Indian TB Test Market Picture this: Co-Diagnostics, a molecular diagnostics player, is on the brink of a significant leap toward expanding its footprint in India with its TB test. The stage is set, with a clinical study already turning in results as solid as old boots. We're talking sensitivity hovering around 97.3% and specificity at...

Continue Reading
Tamara Toles O'Laughlin: Steering Philanthropy's Next Era

Updated Category News Views 52

Leadership Transition in Philanthropy Everyone knows the drill: leadership changes are often a toss-up. You could get a fresh burst of energy or spend years longing for the good old days. That's where The New York Women's Foundation finds itself as they hand over the reins from Ana L. Oliveira to Tamara Toles O'Laughlin. In a world where philanthropic shifts can either...

Continue Reading
Fairfax Crest: A New Chapter in Affordable Housing

Updated Category News Views 31

Setting the Stage: Fairfax Crest's Grand Opening You know what's better than leaving a dusty old car park underutilized? Turning it into homes for folks who really need them. That's exactly what went down in Fairfax County as they cut the ribbon on their latest affordable housing project, Fairfax Crest. We're talking 279 affordable units sprouting up where there once lay...

Continue Reading
Hisense's AI S7 Dishwasher Revolutionizes Home Living

Updated Category News Views 75

The Intersection of AI and Home Appliances In a world where families are looking for more efficiency, Hisense isn’t just tossing another dishwasher into the wild. No, they're aiming to redefine the whole damn experience of household chores with their latest brainchild, the Hisense S7 Dishwasher. Packed with AI smarts and an impressive tech bouquet, this bad boy is all...

Continue Reading
Personalis Merger Faces Investigation: $16.25 Offers Scrutinized

Updated Category News Views 38

Market Storm or Light Drizzle? When the sharks smell blood or the legal eagles start circling, you know something stinks. BFA Law is sniffing around, and it isn’t just for sport. They’re putting their magnifying glass on this curious $16.25 per share transaction where Tempus AI plans to gobble up Personalis lock, stock, and barrel. For investors holding NASDAQ:PSNL,...

Continue Reading
XCMG Climbs Fortune China 500: Strengthens Global Edge

Updated Category News Views 83

XCMG's Ascent on the Fortune China 500 When it comes to scaling new heights, XCMG Machinery is clearly in the driver's seat, roaring up the Fortune China 500 to claim the 202nd spot, leaping ten ranks from last year. While others may coast, XCMG's trajectory is anything but idle, retaining its crown among Chinese construction machinery titans. The recent summit in Chengdu...

Continue Reading
Common Thread Advisors: Transforming Change in Business

Updated Category News Views 41

Navigating the Storm of Change: A New Player in Town You know, just when you think you've got the business world figured out, something sharp comes along. Today, it’s Common Thread Advisors, making its grand entrance to help organizations steer through the dense fog of change. This isn’t your everyday, run-of-the-mill consultancy. No sir, they’re out here with a...

Continue Reading
Bybit’s Gold Yield Offer: 2.83% APR on XAUT

Updated Category News Views 74

Gold Savings with a Tokenized Twist Taking a wild swing at pairing gold and crypto in a digestible package, Bybit and the XAUE Protocol have teamed up to offer a 2.83% fixed APR on XAUT Savings. If you're itching for something that doesn’t make your stomach churn like some of the wild crypto rides, this just might soothe those nerves. Or maybe it’s just a slick way to...

Continue Reading
Fluence Faces Legal Battle Amid Major Stock Plunge

Updated Category News Views 55

The High Stakes for Fluence Energy Investors Well, here's a plot twist, or perhaps not for those who've been keeping an eye on the renewable energy sector. Fluence Energy (NASDAQ:FLNC), a supposed heavyweight in energy storage and renewable innovations, is tangled in a legal web over securities fraud. As of now, Fluence has been slapped with a class action lawsuit...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionizing Safety Monitoring with LifeSphere Advanced Signals

Updated Category News Views 244

Revolutionizing Pharmacovigilance with AI In the realm of life sciences, ensuring patient safety is paramount. Recently, a prominent pharmaceutical organization announced its partnership with ArisGlobal in implementing the innovative LifeSphere Advanced Signals. This advanced pharmacovigilance solution utilizes automation and AI-driven insights to enhance signal detection...

Continue Reading
Arcellx Inc. Under Fire: Shareholder Concerns Mounting Fast

Updated Category News Views 163

What's Going Down with Arcellx? Kickin’ off with the news—Arcellx Inc. (NASDAQ: ACLX) is under the microscope for potential shareholder shenanigans. I mean, there’s chatter coming from the Ademi Firm, pointing fingers at the board for not playing fair with the shareholders. Not exactly a good look, right? This takes me back to times when I’ve seen boards pulling...

Continue Reading
Memecoins Rally: The Strategic Advantage of Investing in PEPE

Updated Category News Views 164

The Surge of Pepe and Shiba Inu in Recent Days In a surprising turn of events, the memecoins Pepe and Shiba Inu have experienced remarkable gains amidst a largely negative market atmosphere. While the broader cryptocurrency market has been facing some challenges, these two coins have struck a positive chord with traders and investors alike. Market Performance: Gains...

Continue Reading
Transforming the Electrical Grid: Lessons from Advanced Technologies

Updated Category News Views 176

Modernizing the Electrical Grid: An Urgent Need As the demand for energy continues to increase, the necessity for a robust and efficient electrical grid becomes increasingly evident. States across the nation are actively seeking solutions to modernize their utilities and ensure a reliable energy supply. One of the most promising approaches involves the implementation of...

Continue Reading
WEX Inc. CFO's Recent Stock Sale: Implications for Investors

Updated Category News Views 122

WEX Inc. CFO's Notable Stock Sale WEX Inc. (NYSE: WEX) Chief Financial Officer Jagtar Narula recently made headlines by selling 508 shares of the company's stock. Priced at $200 each, this sale totaled an impressive $101,600. Transactions of this magnitude naturally attract attention from both investors and market analysts. Context Behind the Sale The sale occurred under...

Continue Reading